Trending Stock News

As Sage Therapeutics (Call) (SAGE) Shares Declined, Eventide Asset Management Decreased Holding; As Intuitive Surgical Com New (ISRG) Stock Value Rose, Redmond Asset Management Has Increased by $1.09 Million Its Position

Sage Therapeutics, Inc. (NASDAQ:SAGE) Logo

Eventide Asset Management Llc decreased its stake in Sage Therapeutics Inc (Call) (SAGE) by 37.11% based on its latest 2017Q4 regulatory filing with the SEC. Eventide Asset Management Llc sold 59,000 shares as the company’s stock declined 6.84% with the market. The institutional investor held 100,000 shares of the health care company at the end of 2017Q4, valued at $16.47M, down from 159,000 at the end of the previous reported quarter. Eventide Asset Management Llc who had been investing in Sage Therapeutics Inc (Call) for a number of months, seems to be less bullish one the $7.21 billion market cap company. The stock decreased 0.63% or $0.98 during the last trading session, reaching $154.91. About 14,299 shares traded. Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 135.95% since May 24, 2017 and is uptrending. It has outperformed by 124.40% the S&P500.

Redmond Asset Management Llc increased its stake in Intuitive Surgical Inc Com New (ISRG) by 193.24% based on its latest 2017Q4 regulatory filing with the SEC. Redmond Asset Management Llc bought 3,001 shares as the company’s stock rose 11.58% while stock markets declined. The institutional investor held 4,554 shares of the health care company at the end of 2017Q4, valued at $1.66 million, up from 1,553 at the end of the previous reported quarter. Redmond Asset Management Llc who had been investing in Intuitive Surgical Inc Com New for a number of months, seems to be bullish on the $51.82 billion market cap company. The stock decreased 0.30% or $1.36 during the last trading session, reaching $457.35. About 32,022 shares traded. Intuitive Surgical, Inc. (NASDAQ:ISRG) has risen 58.43% since May 24, 2017 and is uptrending. It has outperformed by 46.88% the S&P500.

Among 20 analysts covering Intuitive Surgical Inc (NASDAQ:ISRG), 14 have Buy rating, 1 Sell and 5 Hold. Therefore 70% are positive. Intuitive Surgical Inc had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, April 16 by J.P. Morgan. Morgan Stanley maintained the stock with “Overweight” rating in Wednesday, April 18 report. The stock of Intuitive Surgical, Inc. (NASDAQ:ISRG) has “Buy” rating given on Friday, January 26 by Cantor Fitzgerald. Canaccord Genuity maintained the stock with “Hold” rating in Wednesday, April 18 report. The stock has “Overweight” rating by Morgan Stanley on Tuesday, July 25. RBC Capital Markets maintained Intuitive Surgical, Inc. (NASDAQ:ISRG) rating on Thursday, January 7. RBC Capital Markets has “Sector Perform” rating and $610.0 target. The rating was downgraded by BTIG Research on Friday, April 1 to “Neutral”. The firm has “Buy” rating by Citigroup given on Tuesday, February 6. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, April 9 report. The firm has “Outperform” rating by Leerink Swann given on Thursday, January 14.

More notable recent Intuitive Surgical, Inc. (NASDAQ:ISRG) news were published by: Investorplace.com which released: “Does Intuitive Surgical, Inc. Have Any More Room to Run?” on May 11, 2018, also Nasdaq.com with their article: “New Study Shows Robotic-Assisted Surgery Benefits for Inguinal Hernia Repair” published on May 03, 2018, Nasdaq.com published: “Carve Through Weakness in Mazor Robotics Ltd. Stock With Surgical Precision” on May 14, 2018. More interesting news about Intuitive Surgical, Inc. (NASDAQ:ISRG) were released by: Seekingalpha.com and their article: “Intuitive Surgical At The Cutting Edge” published on May 13, 2018 as well as Seekingalpha.com‘s news article titled: “Earnings Season’s Biggest Winners And Losers… So Far” with publication date: April 26, 2018.

Investors sentiment increased to 12.48 in Q4 2017. Its up 11.44, from 1.04 in 2017Q3. It increased, as 23 investors sold ISRG shares while 21 reduced holdings. 91 funds opened positions while 458 raised stakes. 191.92 million shares or 430.23% more from 36.20 million shares in 2017Q3 were reported. Yhb Investment Advsr holds 0.65% or 10,469 shares. Lmr Prns Llp has 0.56% invested in Intuitive Surgical, Inc. (NASDAQ:ISRG). Shell Asset stated it has 30,187 shares. Northern Tru Corp accumulated 0.13% or 1.37 million shares. Citadel Advisors Lc has invested 0.03% in Intuitive Surgical, Inc. (NASDAQ:ISRG). Creative Planning reported 23,497 shares or 0.04% of all its holdings. Kcm Investment Advisors Limited Liability Co owns 795 shares. 18 were accumulated by Ent Financial Corporation. Sei invested in 0.1% or 76,810 shares. Moreover, Kings Point Capital Mngmt has 0.01% invested in Intuitive Surgical, Inc. (NASDAQ:ISRG) for 102 shares. Geode Cap Limited Liability Com stated it has 0.16% of its portfolio in Intuitive Surgical, Inc. (NASDAQ:ISRG). Df Dent & holds 305,292 shares or 2.8% of its portfolio. United Kingdom-based Horseman Cap Mgmt Ltd has invested 0.23% in Intuitive Surgical, Inc. (NASDAQ:ISRG). Gulf Interest Financial Bank (Uk) reported 0.17% of its portfolio in Intuitive Surgical, Inc. (NASDAQ:ISRG). Ameriprise Finance reported 62,799 shares stake.

Since January 30, 2018, it had 0 insider buys, and 24 selling transactions for $117.80 million activity. The insider SMITH LONNIE M sold 18,000 shares worth $7.72M. MOHR MARSHALL sold $3.37M worth of stock. 28,525 shares were sold by GUTHART GARY S, worth $11.82M on Monday, February 5. $999,198 worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) was sold by Friedman Michael A. The insider MELTZER MARK J sold 24,000 shares worth $10.39 million. $1.11 million worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) was sold by BARRATT CRAIG H on Friday, March 9.

More news for Sage Therapeutics, Inc. (NASDAQ:SAGE) were recently published by: Seekingalpha.com, which released: “Sage Therapeutics 2018 Q1 – Results – Earnings Call Slides” on May 03, 2018. Streetinsider.com‘s article titled: “Omega’s 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More…)” and published on May 15, 2018 is yet another important article.

Analysts await Sage Therapeutics, Inc. (NASDAQ:SAGE) to report earnings on August, 2. They expect $-1.87 earnings per share, up 0.53% or $0.01 from last year’s $-1.88 per share. After $-1.68 actual earnings per share reported by Sage Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 11.31% negative EPS growth.

Investors sentiment increased to 1.49 in 2017 Q4. Its up 0.28, from 1.21 in 2017Q3. It is positive, as 27 investors sold SAGE shares while 56 reduced holdings. 63 funds opened positions while 61 raised stakes. 41.45 million shares or 7.53% more from 38.55 million shares in 2017Q3 were reported. 70,091 were accumulated by Element Capital Management Limited Liability Company. Brinker Capital reported 2,447 shares. Nuveen Asset Mngmt Ltd Liability Corp invested 0.01% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Moreover, Amundi Pioneer Asset Inc has 0.03% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 121,008 shares. Cibc holds 4,430 shares or 0% of its portfolio. Ubs Asset Mgmt Americas holds 175,630 shares or 0.02% of its portfolio. Essex Inv Management Company Ltd Company owns 0.14% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 6,431 shares. Prudential Financial owns 3,854 shares. Northern Tru owns 444,158 shares or 0.02% of their US portfolio. Farallon Cap Management Ltd Company owns 400,000 shares. Fincl Bank Of Montreal Can owns 0% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 336 shares. Voloridge Investment Mgmt Ltd Liability Corp holds 0.19% in Sage Therapeutics, Inc. (NASDAQ:SAGE) or 53,908 shares. Columbus Circle reported 21,222 shares stake. Keybank Association Oh has invested 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Clarivest Asset Ltd Co owns 5,140 shares for 0.01% of their portfolio.

Since December 14, 2017, it had 0 insider buys, and 6 insider sales for $42.42 million activity. PAUL STEVEN M sold $10.00M worth of stock. 44,000 shares were sold by Kanes Stephen, worth $7.80M. $9.96M worth of stock was sold by STARR KEVIN P on Tuesday, April 17. Robichaud Albert also sold $9.57M worth of Sage Therapeutics, Inc. (NASDAQ:SAGE) on Thursday, December 14. On Tuesday, May 8 FRATES JAMES M sold $1.08M worth of Sage Therapeutics, Inc. (NASDAQ:SAGE) or 7,000 shares.

Intuitive Surgical, Inc. (NASDAQ:ISRG) Institutional Positions Chart

Ash

Leave a Reply

Your email address will not be published. Required fields are marked *